Core Insights - The Shandong Provincial Medical Insurance Bureau is conducting research on pharmaceutical pricing and procurement in Weihai to understand the operational status of pharmaceutical companies and the implementation of centralized procurement policies [1][3][5] Group 1: Research Focus - The research aims to gather insights on the operational development of pharmaceutical enterprises, the execution of centralized procurement policies, and the direct settlement of medical insurance funds for drugs and medical consumables [1] - The study also emphasizes understanding the needs of enterprises, the service experience of the public in purchasing medications, and the support for specialty industries through medical insurance [1] Group 2: Company Engagement - During the visit to Weigao Group, company representatives shared their experiences with centralized procurement and provided suggestions for improving procurement rules and drug traceability management [3] - The research team also visited a retail pharmacy to observe the reimbursement process and assess the challenges faced by pharmacies in managing drug sales and inventory [5] Group 3: Industry Development - Discussions with local ginseng industry representatives focused on incorporating ginseng products into the medical insurance catalog and expanding market share through participation in centralized procurement [7] - The Weihai Medical Insurance Bureau has been recognized for its effective price procurement work, particularly in direct settlement of medical insurance funds, which has provided valuable experience for broader implementation across the province [8]